… conversion of persistent mild and common COVID-19 patient versus standard … randomized
clinical trial of using hydroxychloroquine in patients with mainly mild to moderate COVID-19, …

… with mild-to-moderate COVID-19, we conducted a phase 2 randomized, open-label, …
reduced clinical deterioration of mild COVID-19 by 91% in a randomized clinical trial [20]. …

… They were stratified by mild or moderate illnesses within 4 … with mild clinical COVID-19
symptoms and with antimicrobial therapy for subjects presenting with moderate clinical COVID-19 …

… Enrolling only patients without symptoms or with mild disease also made it difficult to assess
… , in this randomized trial of patients with asymptomatic to mildly symptomatic COVID-19, …

… to severe COVID-19. Non-hospitalized adults with mild COVID-19 were randomized to …
clinical guidance for management of adult COVID-19 patients by the Government of India or …

… 32 ITT COVID-19 subjects who were randomized to receive losartan ARB in addition to SOC
at the time versus SOC alone. We noted no significant differences in progression from mild …

… The randomization was stratified based on baseline disease severity into mild and moderate
COVID-19. Patients were assigned to stratified randomized treatments based on a central, …

… -positive coronavirus disease 2019 (COVID-19) patients. A total of 210 RT-PCR-positive
COVID-19 … is a safe and effective drug for treating patients with mild and moderate covid-19. …

… In patients with mild-to-moderate COVID-19 managed without … of azithromycin in patients
with mild-to-moderate COVID-19. … any randomised trials in patients with COVID-19 managed in …

… Trial design, randomisation, and procedures This study was a multicentre, randomised,
parallel, open label trial of hydroxychloroquine in patients admitted to hospital with covid-19. …